Annual Meeting Home Past & Future Meetings

Back to Annual Meeting Program

Impact of Immunocompromised Status on Outcomes in Patients with Necrotizing Soft Tissue Infection
*Emily Z Keung, *Xiaoxia Liu, *Afrin Nuzhad, *Christopher D Adams, Stanley W Ashley, *Reza Askari
Brigham and Women's Hospital, Boston, MA

Objective: To evaluate outcomes and factors associated with in-hospital mortality among immunosuppressed patients with necrotizing soft tissue infection (NSTI). Design: Single institution retrospective cohort study. Setting: Tertiary academic hospital/cancer center. Patients: All patients with NSTI between November 25, 1995 and April 25, 2011. Main Outcome Measures: In-hospital mortality. Results: 201 patients were diagnosed with NSTI. 46 were immunosuppressed (active malignancy, chemotherapy/radiation treatment, prior solid organ/bone marrow transplant on chronic immunosuppression, steroids, HIV/AIDS). At presentation, immunocompromised patients had lower systolic blood pressure (105 vs 112mmHg, p=0.0213), glucose (124 vs 134mg/dL, p=0.0325), and white blood cell count (6.6 vs 17.2K/uL, p=0.0001). Immunocompromised patients were less likely to be transferred from another institution (26.1% vs 52.9%, p=0.0014), admitted to a surgical service (45.7% vs 83.2%, p<0.0001), and undergo surgical debridement on admission (4.4% vs 61.3%, p=0.0007). Time to diagnosis and first surgery were delayed in immunocompromised patients (table). Immunocompromised patients had higher in-hospital mortality (39.1% vs 19.4%, p=0.0097). In this patient population, pressor/inotropic requirement (p=0.0062, OR 49.32, 95% CI 3.03-803.18) and fewer surgical debridements (p=0.0028, OR 0.142, 95% CI 0.040-0.510) were independently associated with in-hospital mortality. Conclusions: Immunocompromised status in NSTI patients is associated with delay in diagnosis, delay in surgical treatment and higher in-hospital mortality. At presentation, immunocompromised patients often failed to exhibit typical clinical and laboratory signs of NSTI. It is therefore paramount that physicians caring for this patient population have a heightened level of suspicion for NSTI and consider early surgical evaluation and treatment.
VariableAll Patients (%)
Immunosuppressed (%)
Immunocompetent (%)
P value
Time from presentation to diagnosis<0.0001
<12hrs125 (62.2)22 (47.8)103 (66.5)-
12-24hrs35 (17.4)18 (39.1)17 (11.0)-
>24hrs38 (18.9)6 (13.1)32 (20.6)-
Unknown3 (1.5)0 (0)3 (1.9)-
Time from presentation to first surgery0.0012
<12hrs118 (58.7)17 (37.0)101 (65.2)-
12-24hrs35 (17.4)15 (32.6)20 (12.9)-
>24hrs37 (18.4)7 (15.2)30 (19.4)-
No surgery8 (4.0)7 (15.2)1 (0.6)-
Unknown3 (1.5)0 (0)3 (1.9)-

Back to Annual Meeting Program


Abstract Submission Deadline:
May 5, 2014

Housing Deadline:
August 13, 2014

Early Bird Registration Deadline:
August 11, 2014
© 2018 New England Surgical Society. All Rights Reserved. Privacy Policy.